COVID-19

Impact of Post-acute Sequelae of sars-cov-2 (PASC) on Health-related Quality of Life: A Comparison with U.S. Population Norms

Presenting Author(s)

Zina J. Ahn, BA (she/her/hers)

Clinical Research Coordinator
University of Pennsylvania

GB

Gwen Baraniecki-Zwil

Medical Student
Lewis Katz School of Medicine at Temple University
Ava-Kathleen Rybicki, MS, MA

Clinical Research Coordinator
University of Pennsylvania
Maayan Levy

Assistant professor
Stanford
NM

Nuala J. Meyer, MD MS

Professor of Medicine
University of Pennsylvania Perelman School of Medicine
EL

Eline Luning Prak

Professor of Pathology and Laboratory Medicine
University of Pennsylvania
Sara Cherry, PhD (she/her/hers)

John W. Eckman Professor of Medical Science
University of Pennsylvania
CT

Christoph Thaiss

Assistant Professor
Stanford
LP

Liliana E. Pezzin, PhD, JD

Professor
Medical College of Wisconsin
Timothy Dillingham, MD, MS

Physician
University of Pennsylvania
Benjamin Abramoff, MD, MS

Physician
University of Pennsylvania

Compare EQ-5D responses between individuals with PASC and the US population norm to identify areas of functional impairment and reduced well-being.
Interpret differences in EQ-5D dimension and index scores to draw conclusions about the long-term impact of PASC on patients’ quality of life.
Describe the EQ-5D instrument and its role in assessing health-related quality of life in both general and clinical populations.